ORAGENICS, INC. Operating Cash Flow
ORAGENICS, INC. (OGEN) reported Operating Cash Flow of -$4.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- ORAGENICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.19M.
- ORAGENICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.20M.
- ORAGENICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.84M.
- ORAGENICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.98M.
- ORAGENICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$9.25M.
- ORAGENICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$8.60M.
- ORAGENICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$7.29M.
- ORAGENICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$15.23M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.39M 10-Q · filed 2026-08-13 | -$7.22M derived: sum of 3 quarters · filed 2026-08-13 | -$10.21M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$2.20M 10-Q · filed 2026-05-08 | -$5.04M derived: sum of 2 quarters · filed 2026-05-08 | -$8.02M derived: sum of 3 quarters · filed 2026-05-08 | -$9.33M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$5.82M derived: sum of 2 quarters · filed 2026-03-16 | -$7.13M derived: sum of 3 quarters · filed 2026-08-13 | -$9.25M 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.30M derived: sum of 2 quarters · filed 2026-08-13 | -$6.41M 10-Q · filed 2025-11-07 | -$8.43M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$3.43M 10-Q · filed 2026-08-13 | -$5.44M derived: sum of 3 quarters · filed 2026-08-13 | -$7.42M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$2.11M 10-Q · filed 2026-05-08 | -$4.13M derived: sum of 2 quarters · filed 2026-05-08 | -$6.10M derived: sum of 3 quarters · filed 2026-05-08 | -$7.65M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$3.99M derived: sum of 2 quarters · filed 2026-03-16 | -$5.53M derived: sum of 3 quarters · filed 2026-03-16 | -$8.60M 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$3.51M derived: sum of 2 quarters · filed 2025-11-07 | -$6.58M 10-Q · filed 2025-11-07 | -$7.68M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$4.61M 10-Q · filed 2025-08-08 | -$5.71M derived: sum of 3 quarters · filed 2025-08-08 | -$7.21M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | -$3.06M 10-Q · filed 2025-05-09 | -$4.17M derived: sum of 2 quarters · filed 2025-05-09 | -$5.67M derived: sum of 3 quarters · filed 2025-05-09 | -$8.25M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$2.61M derived: sum of 2 quarters · filed 2025-03-14 | -$5.18M derived: sum of 3 quarters · filed 2025-03-14 | -$7.29M 10-K · filed 2025-03-14 | |
| 2023-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$4.08M derived: sum of 2 quarters · filed 2024-11-13 | -$6.19M 10-Q · filed 2024-11-13 | -$8.62M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$4.69M 10-Q · filed 2024-08-09 | -$7.12M derived: sum of 3 quarters · filed 2024-08-09 | -$10.89M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | -$2.11M 10-Q · filed 2024-05-15 | -$4.54M derived: sum of 2 quarters · filed 2024-05-15 | -$8.32M derived: sum of 3 quarters · filed 2024-05-15 | -$11.70M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$6.21M derived: sum of 2 quarters · filed 2024-03-29 | -$9.59M derived: sum of 3 quarters · filed 2024-03-29 | -$15.23M 10-K · filed 2024-03-29 | |
| 2022-09-30 | -$3.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$7.16M derived: sum of 2 quarters · filed 2023-11-09 | -$12.80M 10-Q · filed 2023-11-09 | -$15.28M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$9.02M 10-Q · filed 2023-08-11 | -$11.50M derived: sum of 3 quarters · filed 2023-08-11 | -$16.08M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$5.64M 10-Q · filed 2023-05-12 | -$8.12M derived: sum of 2 quarters · filed 2023-05-12 | -$12.70M derived: sum of 3 quarters · filed 2023-05-12 | -$14.78M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$2.48M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | -$7.06M derived: sum of 2 quarters · filed 2023-04-17 | -$9.14M derived: sum of 3 quarters · filed 2023-04-17 | -$13.47M 10-K · filed 2023-04-17 | |
| 2021-09-30 | -$4.58M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2023-04-14 | -$6.66M derived: sum of 2 quarters · filed 2023-04-14 | -$10.99M 10-Q/A · filed 2023-04-14 | -$11.59M 10-Q · filed 2021-11-15 | -$14.62M derived: sum of 4 quarters · filed 2023-04-14 |
| 2021-06-30 | -$2.08M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2023-04-14 | -$6.41M 10-Q/A · filed 2023-04-14 | -$10.04M derived: sum of 3 quarters · filed 2023-04-14 | -$14.70M derived: sum of 4 quarters · filed 2023-04-14 | |
| 2021-03-31 | -$4.33M 10-Q/A · filed 2023-04-14 | -$7.96M derived: sum of 2 quarters · filed 2023-04-14 | -$12.62M derived: sum of 3 quarters · filed 2023-04-14 | -$17.46M derived: sum of 4 quarters · filed 2023-04-14 | |
| 2020-12-31 | -$3.63M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-29 | -$8.30M derived: sum of 2 quarters · filed 2022-07-29 | -$13.13M derived: sum of 3 quarters · filed 2022-07-29 | -$16.95M 10-K/A · filed 2022-07-29 | |
| 2020-09-30 | -$4.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$9.50M derived: sum of 2 quarters · filed 2021-11-15 | -$13.32M 10-Q · filed 2021-11-15 | -$17.26M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$8.66M 10-Q · filed 2021-08-16 | -$12.59M derived: sum of 3 quarters · filed 2021-08-16 | -$15.97M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$3.82M 10-Q · filed 2021-05-03 | -$7.76M derived: sum of 2 quarters · filed 2021-05-03 | -$11.14M derived: sum of 3 quarters · filed 2021-05-03 | -$14.63M derived: sum of 4 quarters · filed 2021-05-03 | |
| 2019-12-31 | -$3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$7.31M derived: sum of 2 quarters · filed 2021-03-01 | -$10.80M derived: sum of 3 quarters · filed 2021-03-01 | -$13.01M 10-K · filed 2021-03-01 | |
| 2019-09-30 | -$3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$6.87M derived: sum of 2 quarters · filed 2020-11-10 | -$9.08M 10-Q · filed 2020-11-10 | -$12.05M derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | -$3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$5.70M 10-Q · filed 2020-08-14 | -$8.68M derived: sum of 3 quarters · filed 2020-08-14 | -$11.13M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$2.21M 10-Q · filed 2020-05-15 | -$5.19M derived: sum of 2 quarters · filed 2020-05-15 | -$7.64M derived: sum of 3 quarters · filed 2020-05-15 | -$9.92M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | -$2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$5.43M derived: sum of 2 quarters · filed 2020-03-04 | -$7.71M derived: sum of 3 quarters · filed 2020-03-04 | -$9.08M 10-K · filed 2020-03-04 | |
| 2018-09-30 | -$2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$4.74M derived: sum of 2 quarters · filed 2019-11-14 | -$6.10M 10-Q · filed 2019-11-14 | -$7.46M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | -$2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$3.65M 10-Q · filed 2019-08-14 | -$5.01M derived: sum of 3 quarters · filed 2019-08-14 | -$6.35M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$1.37M 10-Q · filed 2019-05-13 | -$2.73M derived: sum of 2 quarters · filed 2019-05-13 | -$4.06M derived: sum of 3 quarters · filed 2019-05-13 | -$5.83M derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$2.70M derived: sum of 2 quarters · filed 2019-03-29 | -$4.46M derived: sum of 3 quarters · filed 2019-03-29 | -$6.36M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$3.10M derived: sum of 2 quarters · filed 2018-11-13 | -$5.01M 10-Q · filed 2018-11-13 | -$6.97M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$3.67M 10-Q · filed 2018-08-13 | -$5.63M derived: sum of 3 quarters · filed 2018-08-13 | -$7.20M derived: sum of 4 quarters · filed 2018-08-13 | |
| 2017-03-31 | -$1.90M 10-Q · filed 2018-05-15 | -$3.86M derived: sum of 2 quarters · filed 2018-05-15 | -$5.44M derived: sum of 3 quarters · filed 2018-05-15 | -$7.36M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$3.54M derived: sum of 2 quarters · filed 2018-02-16 | -$5.46M derived: sum of 3 quarters · filed 2018-02-16 | -$7.08M 10-K · filed 2018-02-16 | |
| 2016-09-30 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$3.49M derived: sum of 2 quarters · filed 2017-10-31 | -$5.11M 10-Q · filed 2017-10-31 | -$6.77M derived: sum of 4 quarters · filed 2017-10-31 | |
| 2016-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$3.54M 10-Q · filed 2017-08-14 | -$5.20M derived: sum of 3 quarters · filed 2017-08-14 | -$6.54M derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | -$1.62M 10-Q · filed 2017-05-15 | -$3.28M derived: sum of 2 quarters · filed 2017-05-15 | -$4.62M derived: sum of 3 quarters · filed 2017-05-15 | ||
| 2015-12-31 | -$1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$3.00M derived: sum of 2 quarters · filed 2017-02-27 | -$5.19M 10-K · filed 2017-02-27 | ||
| 2015-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$3.53M 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | -$2.19M 10-Q · filed 2016-08-15 | ||||
| 2013-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | -$3.96M derived: sum of 2 quarters · filed 2013-10-25 | -$5.55M 10-Q · filed 2013-10-25 | -$7.29M derived: sum of 4 quarters · filed 2013-10-25 | |
| 2013-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$3.58M 10-Q · filed 2013-08-12 | -$5.32M derived: sum of 3 quarters · filed 2013-08-12 | -$6.50M derived: sum of 4 quarters · filed 2013-10-25 | |
| 2013-03-31 | -$1.58M 10-Q · filed 2013-05-15 | -$3.32M derived: sum of 2 quarters · filed 2013-05-15 | -$4.50M derived: sum of 3 quarters · filed 2013-10-25 | -$5.65M derived: sum of 4 quarters · filed 2013-10-25 | |
| 2012-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | -$2.92M derived: sum of 2 quarters · filed 2013-10-25 | -$4.07M derived: sum of 3 quarters · filed 2013-10-25 | -$5.21M 10-K · filed 2013-03-26 | |
| 2012-09-30 | -$1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | -$2.33M derived: sum of 2 quarters · filed 2013-10-25 | -$3.47M 10-Q · filed 2013-10-25 | -$4.86M derived: sum of 4 quarters · filed 2013-10-25 | |
| 2012-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$2.29M 10-Q · filed 2013-08-12 | -$3.68M derived: sum of 3 quarters · filed 2013-08-12 | -$5.20M derived: sum of 4 quarters · filed 2013-08-12 | |
| 2012-03-31 | -$1.14M 10-Q · filed 2013-05-15 | -$2.53M derived: sum of 2 quarters · filed 2013-05-15 | -$4.05M derived: sum of 3 quarters · filed 2013-05-15 | -$5.51M derived: sum of 4 quarters · filed 2013-05-15 | |
| 2011-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | -$2.91M derived: sum of 2 quarters · filed 2013-03-26 | -$4.37M derived: sum of 3 quarters · filed 2013-03-26 | -$5.49M 10-K · filed 2013-03-26 | |
| 2011-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$2.98M derived: sum of 2 quarters · filed 2012-11-14 | -$4.10M 10-Q · filed 2012-11-14 | -$5.88M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | -$2.58M 10-Q · filed 2012-08-10 | -$4.36M derived: sum of 3 quarters · filed 2012-08-10 | -$5.75M derived: sum of 4 quarters · filed 2012-08-10 | |
| 2011-03-31 | -$1.12M 10-Q · filed 2012-05-15 | -$2.90M derived: sum of 2 quarters · filed 2012-05-15 | -$4.29M derived: sum of 3 quarters · filed 2012-05-15 | ||
| 2010-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$3.17M derived: sum of 2 quarters · filed 2012-04-16 | -$6.45M 10-K · filed 2012-04-16 | ||
| 2010-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$4.68M 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | -$3.28M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |